Genenta Science (GNTA)

• Market cap: $16.7M
• 1 day: 0.9%
• 5 days: -3.19%
• 1 month: -1.64%
• 3 months: -45.52%
• 6 months: -88.58%
• Year to date: -49.77%
• 1 year: -81.93%
• 5 years: -93.56%
• 10 years: -93.56%
• Sector: Healthcare
• Industry: Biotechnology

About: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Employees: 9